Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: does it help tailor adjuvant treatment?

More about this publication

Annals of oncology : official journal of the European Society for Medical Oncology
  • Volume 35
  • Issue nr. 5
  • Pages 409-411
  • Publication date 01-05-2024

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.